Visar resultat för..."v%E5dan"

Now in its fifth edition, Fundamentals of Corporate Finance continues to offer a clear, engaging introduction to the core principles of modern corporate finance. Blending accessible language with real-world European examples, the book equips students with the essential knowledge and tools needed to understand how financial decisions are made in a dynamic global environment.

Drawing on the authors’ extensive academic and industry expertise, the text presents a solid conceptual framework supported by practical applications, integrated theory, and up-to-date case insights. It’s an ideal resource for students seeking to grasp the fundamentals of corporate finance and the evolving strategies firms use to navigate today’s financial landscape.

Key Features

Fundamentals of Corporate Finance is available through McGraw Hill’s Connect® learning platform as an interactive, adaptive eBook alongside a wealth of ready-made course content for teaching, learning, practice and assessment. With a variety of tools to help with course management, insight and tracking, Connect helps faculty and institutions improve student outcomes and deliver courses more efficiently. To learn more, visit mheducation.co.uk/connect.

David Hillier is Associate Principal and Executive Dean of Strathclyde Business School and Professor of Finance at the University of Strathclyde. David was recognized as being in the top 3 per cent of the most prolific finance researchers in the world over the past 50 years (Heck and Cooley, 2009) and appears regularly in the media as a business commentator. David teaches regularly in development programs for executives and has taught courses for a wide variety of professional clients, including the World Bank and the National Health Service in the UK. He is part of the editorial board of several international finance journals.

Rama Seth is an Associate Professor of Finance at the Copenhagen Business School and Professor (on Leave) in the Finance and Control Department at the Indian Institute of Management Calcutta. She earned her PhD at Columbia University in New York City and has served at leading international policy-making bodies such as the Federal Reserve Bank, The World Bank, the International Monetary Fund, the Bank for International Settlements, and the United Nations. She has been selected for the 2018 IP 50 Women in Education Leaders Award.

Tamoxifen is a pioneering medicine for the treatment and prevention of breast cancer. It is the first drug targeted therapy in cancer to be successful. Tamoxifen targets the tumor estrogen receptor. The therapy is known to have saved the lives of millions of women over the past 40 years.

This monograph, written by V. Craig Jordan - known as the “father of tamoxifen” - and his Tamoxifen Team at the Georgetown University Washington DC, illustrates the journey of this milestone in medicine. It includes a personal interview with V. Craig Jordan about his four decades of discovery in breast cancer research and treatment. V. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a “failed morning after contraceptive” to become the “gold standard” for the treatment of breast cancer. He contributed to every aspect of tamoxifen application in therapeutics and all aspects of tamoxifen’s pharmacology. He discovered the selective estrogen receptor modulators (SERMs) and explored the new biology of estrogen-induced apoptosis.